全文获取类型
收费全文 | 40091篇 |
免费 | 3558篇 |
国内免费 | 164篇 |
专业分类
耳鼻咽喉 | 372篇 |
儿科学 | 1248篇 |
妇产科学 | 730篇 |
基础医学 | 5947篇 |
口腔科学 | 479篇 |
临床医学 | 4769篇 |
内科学 | 8580篇 |
皮肤病学 | 844篇 |
神经病学 | 4251篇 |
特种医学 | 1352篇 |
外国民族医学 | 1篇 |
外科学 | 5910篇 |
综合类 | 321篇 |
一般理论 | 30篇 |
预防医学 | 3369篇 |
眼科学 | 523篇 |
药学 | 2367篇 |
中国医学 | 81篇 |
肿瘤学 | 2639篇 |
出版年
2023年 | 134篇 |
2022年 | 288篇 |
2021年 | 643篇 |
2020年 | 556篇 |
2019年 | 990篇 |
2018年 | 1099篇 |
2017年 | 902篇 |
2016年 | 923篇 |
2015年 | 1151篇 |
2014年 | 1407篇 |
2013年 | 2012篇 |
2012年 | 2413篇 |
2011年 | 2673篇 |
2010年 | 1705篇 |
2009年 | 1564篇 |
2008年 | 2385篇 |
2007年 | 2458篇 |
2006年 | 2402篇 |
2005年 | 2534篇 |
2004年 | 2426篇 |
2003年 | 2549篇 |
2002年 | 2573篇 |
2001年 | 396篇 |
2000年 | 309篇 |
1999年 | 415篇 |
1998年 | 544篇 |
1997年 | 489篇 |
1996年 | 382篇 |
1995年 | 411篇 |
1994年 | 363篇 |
1993年 | 316篇 |
1992年 | 236篇 |
1991年 | 245篇 |
1990年 | 224篇 |
1989年 | 188篇 |
1988年 | 200篇 |
1987年 | 208篇 |
1986年 | 190篇 |
1985年 | 180篇 |
1984年 | 212篇 |
1983年 | 170篇 |
1982年 | 235篇 |
1981年 | 231篇 |
1980年 | 205篇 |
1979年 | 132篇 |
1978年 | 144篇 |
1977年 | 124篇 |
1976年 | 114篇 |
1974年 | 100篇 |
1972年 | 93篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Delphine Bonnet Matthieu Guivarch Ana?s Palacin Laurent Alric Emilie Bérard Jean-Marc Combis Andre Jean Remy Andre Glibert Jean-Louis Payen Sophie Metivier Karl Barange Herve Desmorat Florence Nicot Florence Abravanel 《World journal of hepatology》2014,6(9):660-669
AIM:To assess,in a routine practice setting,the sus-tained virologic response(SVR) to telaprevir(TPV) or boceprevir(BOC) in hepatitis C virus(HCV) nullresponders or relapsers with severe liver fibrosis.METHODS:One hundred twenty-five patients were treated prospectively for 48 wk with TPV or BOC + pegylated-interferon(peg-INF) α2a + ribavirin(PR) according to standard treatment schedules without randomization.These patients were treated in routine practice settings in 10 public or private health care centers,and the data were prospectively collected.Only patients with severe liver fibrosis(Metavir scores of F3 or F4 upon liver biopsy or liver stiffness assessed by elastography),genotype 1 HCV and who were null-responders or relapsers to prior PR combination therapy were included in this study.RESULTS:The Metavir fibrosis scores were F3 in 35(28%) and F4 in 90(72%) of the patients.In total,62.9% of the patients were null-responders and 37.1% relapsers to the previous PR therapy.The overall SVR rate at 24 wk post-treatment withdrawal was 59.8%.The SVR was 65.9% in the TPV group and 44.1% in the BOC group.Independent predictive factors of an SVR included a response to previous treatment,relapsers vs null-responders [OR = 3.9;(1.4,10.6),P = 0.0084],a rapid virological response(RVR) [OR 6.9(2.6,18.2),P = 0.001] and liver stiffness lower than 21.3 kPa [OR = 8.2(2.3,29.5),P = 0.001].During treatment,63 patients(50.8%) had at least one severe adverse event(SAE) of grade 3 or 4.A multivariate analysis identified two factors associated with SAEs:female gender [OR = 2.4(1.1,5.6),P = 0.037] and a platelet count below 150 × 103/ mm3 [OR = 5.3(2.3,12.4),P ≤ 0.001].CONCLUSION:More than half of these difficult-to-treat patients achieved an SVR and had SAEs in an actual practice setting.The SVR rate was influenced by the response to previous PR treatment,the RVR and liver stiffness. 相似文献
992.
Lei Wang Wei Cui Jean Pierre Kalal Tom Van Hoof Bao-Ge Liu 《Asian Pacific journal of tropical medicine》2014,(10)
Objective:To investigate the effect of osteoporosis and intervertebral disc degeneration on the endplate cartilage injury in rats.Methods:A total of 48 female Sprague Dawley rats(3 months)were randomly divided into Groups A,B,C and D with 12 rats in each group.Osteoporosis and intervertebral disc degeneration composite model,simple degeneration model and simple osteoporosis model were prepared in Groups A,B and C respectively.After modeling,four rats of each group at 12th.18th and 24th week were sacrificed,Intervertebral height of cervical vertebra C6/C7 was measured.Micro-CT was used to image the endplate of cephalic and caudal cartilage at C6/C7 intervertebral disc.Abraded area rate of C6 caudal and C7 cephalic cartilage endplate was calculated,and then C6/C7 intervertebral disc was routinely embedded and sectioned.stained with safranin O to observe histological changes microscopically.Results:At 12,18 and24 weeks,intervertebral disc height of C6/C7 were(0.58±0.09)mm,(0.53±0.04)mm and(0.04±0.06)mm in Group A rats,(0.55±0.05)mm,(0.52±0.07)mm and(0.07±0.05)mm in Group B rats.At 24th week.intervertebral disc height of Group A rats was significantly lower than that of Group B rats(P0.05);intervertebral disc height of Groups A and B rats at each time point were significantly lower than that of Groups C and D(P0.05).There was no significantly statistical difference of intervertebral disc height between Groups C and D(P0.05).At 12 and 18 weeks,the abraded rate of C6 caudal and C7 cephalic cartilage endplate in Group A rats were significantly higher than that in Groups B.C and D rats(P0.05);the abraded rate in Group B was significantly higher than that in Groups C and D(P0.05).Microscopic observation of CT showed that ventral defects in C6caudal or C7 cephalic cartilage endplate in Groups A and B appeared after 12 weeks of modeling;obvious cracks were found in front of the C6 and C7 vertebral body,and cartilage defect shown the trend of"repairing"at 18 and 24 weeks after modeling.Conclusions:Intervertebral disc degeneration and osteoporosis can cause damage to the cartilage endplate.Co-existence of these two factors can induce more serious damage to the endplate.which has possitive correlation with intervertebral disc degeneration.Osteoporosis plays a certain role in intervertebral disc degeneration process,and accelerates the degeneration of intervertebral disc in a specific time window. 相似文献
993.
Amy J. Hoffman Ruth Ann Brintnall Alexander von Eye Lee W. Jones Gordon Alderink Lawrence H. Patzelt Jean K. Brown 《Journal of thoracic disease》2014,6(6):632-640
Background
Post-thoracotomy non-small cell lung cancer (NSCLC) patients report cancer-related fatigue (CRF) as a severe symptom that may increase the occurrence and severity of other symptoms while decreasing functional status and quality of life (QOL). The aim of this pilot study was to describe the effects of a home-based rehabilitative exercise intervention on CRF, other symptoms, functional status, and QOL for post-surgical NSCLC patients starting within days after hospital discharge.Methods
Seven post-thoracotomy NSCLC patients completed the Brief Fatigue Inventory (BFI) measuring CRF severity, and the M.D. Anderson Symptom Inventory measuring symptom severity at pre- and post-surgery, and at the end of each week of the six-week intervention. Additionally, the Medical Outcomes Short-Form-36 measuring physical and mental functional status; and the Quality of Life Index (QLI) measuring QOL were completed pre- and post-surgery, after week 3, and at the end of the intervention (week 6).Results
Participants had a mean age of 65 years, a mean of 6 co-morbid conditions, and initiated the intervention within 4 days after hospital discharge. Participants’ CRF severity scores were reduced to mild levels while the mean number of symptoms decreased from 10.4 post-surgery to 7.0 at week 6 with lower levels of severity and interference. Likewise, participants’ post-intervention functional status and QOL improved to near or above pre-surgical levels.Conclusions
The exercise intervention for post-surgical NSCLC patients showed promising preliminary efficacy in improving CRF, other symptom severity, functional status, and QOL. Further testing via a two-arm randomized controlled trial is being conducted. 相似文献994.
995.
Error in the Abstract in the Article by Maldini et al (Arthritis Care Res [Hoboken], March 2014) 下载免费PDF全文
Carla Maldini Raphaèle Seror Olivier Fain Robin Dhote Zahir Amoura Michel De Bandt Jean‐Luc Delassus Géraldine Falgarone Loïc Guillevin Véronique Le Guern François Lhote Olivier Meyer Jacky Ramanoelina Karim Sacré Yurdagul Uzunhan Jean‐Louis Leroux Xavier Mariette Alfred Mahr 《Arthritis care & research》2014,66(5):794-794
996.
997.
998.
999.
Edouard Cornet Cécile Tomowiak Aline Tanguy‐Schmidt Stéphane Lepretre Jehan Dupuis Pierre Feugier Alain Devidas Clara Mariette Véronique Leblond Catherine Thiéblemont Patricia Validire‐Charpy Laurent Sutton Emmanuel Gyan Jean‐Claude Eisenmann Pascale Cony‐Makhoul Loïc Ysebaert Xavier Troussard the Société Française d'Hématologie 《British journal of haematology》2014,166(3):390-400
A large, multicentre, retrospective survey of patients with hairy cell leukaemia (HCL) was conducted in France to determine the frequency of second malignancies and to analyse the long‐term effects of the established purine nucleoside analogues (PNAs), cladribine and pentostatin. The survey retrospectively reviewed the medical history of patients and their immediate family, clinical and biological presentation at the time of HCL diagnosis, treatment choice, response to treatment, time to relapse and cause of death. Data were collected for 487 patients with HCL. Of the patients included in the survey, 18% (88/487) had a familial history of cancers, 8% (41/487) presented with malignancies before HCL diagnosis and 10% (48/487) developed second malignancies after HCL was diagnosed. An excess incidence of second malignancies was observed, with a standardized incidence ratio (SIR) of 1·86 (95% confidence interval (CI): 1·34–2·51), with no significant difference between PNAs. For second haematological malignancies alone, the SIR was markedly increased at 5·32 (95% CI: 2·90–8·92). This study highlights the high frequency of cancers in HCL patients and their family members. The frequency of second malignancies is notably increased, particularly for haematological malignancies. The respective role of pentostatin and cladribine in the development of second malignancies is debatable. 相似文献